Mark Levental

Papers

Total Citations

H-Index

About

Mark Levental is a leading figure in the fields of robotic surgery and prostate cancer diagnostics, whose work bridges the gap between surgical innovation and patient-centered outcomes. His landmark 2010 study on robotic radical hysterectomy, cited 32 times, was among the first to rigorously compare the clinical outcomes and economic costs of robotic versus traditional approaches, providing critical evidence for the adoption of minimally invasive techniques in gynecologic oncology. Levental further advanced precision medicine with his 2015 investigation into cognitive MRI-targeted biopsy, demonstrating with 17 citations how targeted sampling can accurately hit prostate cancer-positive regions of interest, thereby reducing unnecessary biopsies and improving diagnostic accuracy. His contributions have shaped clinical guidelines and inspired a generation of surgeons to embrace data-driven, cost-conscious care. Beyond these seminal works, Levental is recognized for his commitment to translational research, ensuring that technological breakthroughs translate directly into better patient outcomes. His legacy lies in showing that the future of surgery is not just about what we can do, but what we should do for the patient.